Fenofibrate alleviates insulin resistance by reducing tissue inflammation in obese ovariectomized mice
Abstract Background Fenofibrate is a hypolipidemic peroxisome proliferator-activated receptor α (PPARα) agonist used clinically to reduce hypercholesterolemia and hypertriglyceridemia. Objective We investigated the effects of fenofibrate on insulin resistance and tissue inflammation in a high-fat di...
| 出版年: | Nutrition & Diabetes |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Nature Publishing Group
2023-11-01
|
| オンライン･アクセス: | https://doi.org/10.1038/s41387-023-00249-z |